- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07616102
Effect of Bupivacaine Liposome Injection on Muscle Strength After Total Knee Arthroplasty (TKA)
26 maggio 2026 aggiornato da: General Hospital of Ningxia Medical University
Effect of Bupivacaine Liposome Adductor Canal Block on Muscle Strength After Total Knee Arthroplasty.
This study employs a randomized controlled trial to investigate whether bupivacaine liposome injection for adductor canal block can effectively improve lower limb muscle strength after total knee arthroplasty.
Panoramica dello studio
Stato
Non ancora reclutamento
Condizioni
Intervento / Trattamento
Descrizione dettagliata
Total knee arthroplasty (TKA) involves significant trauma, and postoperative patients often experience moderate to severe pain, which limits early knee joint functional exercise and affects functional recovery.
Peripheral nerve blocks can effectively relieve pain, but while providing adequate analgesia, they may also affect the motor nerves of the lower limbs, increasing the risk of falls when patients begin ambulation.
Some studies have found that the incidence of falls in patients using nerve blocks during the early postoperative period, especially during hospitalization, can be as high as 2% .
The actual incidence in clinical practice may be even higher.
The period of highest risk is when the nerve block effect has not completely subsided and patients begin attempting to ambulate, typically within 24 to 48 hours after surgery.
The loss of muscle strength caused by motor nerve blockade is the most direct cause of postoperative falls, primarily due to severe weakness in key stabilizing muscle groups such as the quadriceps.The adductor canal block has clear advantages.
However, traditional local anesthetics, represented by ropivacaine or bupivacaine, typically provide effective analgesia for only 12-24 hours after a single injection, making it difficult to fully cover the peak pain period of 48-72 hours postoperatively.
Continuous femoral nerve block with ropivacaine can provide prolonged analgesia.
When combined with a sciatic nerve block, it can achieve nearly complete analgesia coverage for the knee.
Its drawback is its association with quadriceps impairment, which may increase the risk of falls.
Continuous adductor canal block also provides prolonged analgesia and has a lesser impact on postoperative muscle strength, but it faces challenges such as catheter placement difficulty and inconvenience for postoperative mobility.
In contrast, bupivacaine liposome can provide analgesia for up to 72 hours.
If, while offering high-quality analgesia, bupivacaine liposome indeed causes significant weakening of quadriceps strength during the critical first 2-3 days after surgery, the safety and effectiveness of early patient ambulation would be greatly compromised, potentially even increasing the risk of falls.
This would contradict the original intent of using the adductor canal block to preserve muscle strength.
Conversely, if it is proven to have a lesser impact on muscle strength compared to continuous femoral nerve block, it could become an almost ideal analgesic option.
Tipo di studio
Interventistico
Iscrizione (Stimato)
80
Fase
- Non applicabile
Contatti e Sedi
Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.
Contatto studio
- Nome: Xin li Ni, MD
- Numero di telefono: 13909586966
- Email: xinlii6@nyfy.com.cn
Backup dei contatti dello studio
- Nome: Qiaojiang Shen
- Numero di telefono: 17829917323
- Email: 2832394521@qq.com
Luoghi di studio
-
-
Ningxia
-
Yinchuan, Ningxia, Cina
- General Hospital of Ningxia Medical University
-
Contatto:
- Xinli Ni, MD
- Numero di telefono: 86-0951-6743252
- Email: xinlini6@nyfy.com.cn
-
-
Criteri di partecipazione
I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.
Criteri di ammissibilità
Età idonea allo studio
- Adulto
- Adulto più anziano
Accetta volontari sani
No
Descrizione
Inclusion Criteria:
- Patients aged 60-75 years scheduled for elective TKA;
- ASA physical status classification II-III;
- BMI 18-30 kg/m²;
- Agreement to participate in this study and provision of signed informed consent.
Exclusion Criteria:
- Individuals with communication barriers such as language or hearing impairments;
- Patients with contraindications to nerve blocks;
- Severe systemic diseases, such as severe renal disease (estimated glomerular filtration rate below 50 mL/min), cardiac disease (congestive heart failure New York Heart Association Class III to IV), or severe hepatic disease defined as a current or past diagnosis of acute/subacute hepatic necrosis, acute liver failure, chronic liver disease, liver abscess, hepatic coma, or hepatorenal syndrome;
- History of long-term opioid use (defined as daily or nearly daily opioid use within the past 3 months).
Piano di studio
Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Doppio
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: a single-injection adductor canal block
An ultrasound-guided adductor canal block is performed via the conventional adductor canal approach.
Under ultrasound guidance, 20 milliliters of 1.33% bupivacaine liposome is injected into the adductor canal.
|
An ultrasound-guided adductor canal block is performed via the conventional adductor canal approach.
Under ultrasound guidance, 20 milliliters of 1.33% bupivacaine liposome is injected into the adductor canal.
|
|
Comparatore attivo: continuous femoral nerve block
An ultrasound-guided perineural sheath block of the femoral nerve is performed via the conventional femoral nerve approach.
A femoral nerve catheter is then placed and connected to an analgesia pump containing 150 milliliters of 0.20% ropivacaine.
|
An ultrasound-guided perineural sheath block of the femoral nerve is performed via the conventional femoral nerve approach.
A femoral nerve catheter is then placed and connected to an analgesia pump containing 150 milliliters of 0.20% ropivacaine.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Quadriceps Muscle Strength
Lasso di tempo: 24 hours after surgery
|
The Maximum Voluntary Isometric Contraction (MVIC) test is used to assess quadriceps strength.
The tester holds a handheld dynamometer.
The patient sits on the bed with legs hanging naturally, and the knee is flexed to 60°.
The patient is instructed to slowly exert force to extend the knee forward.
As the patient exerts force, the tester applies an equal and opposite counterforce with the dynamometer to maintain the position and angle of the lower leg.
The patient sustains maximum effort for 3-5 seconds, and the peak value displayed on the dynamometer is recorded as the result for that trial.
Each leg is tested 2-3 times, with a 60-90 second rest between trials to prevent muscle fatigue from affecting the results.
The average value is recorded as the final outcome.
The unit of measurement is Newtons (N).
|
24 hours after surgery
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Quadriceps muscle strength at other time points
Lasso di tempo: 48 hours after surgery
|
The Maximum Voluntary Isometric Contraction (MVIC) test is used to assess quadriceps strength.
The tester holds a handheld dynamometer.
The patient sits on the bed with legs hanging naturally, and the knee is flexed to 60°.
The patient is instructed to slowly exert force to extend the knee forward.
As the patient exerts force, the tester applies an equal and opposite counterforce with the dynamometer to maintain the position and angle of the lower leg.
The patient sustains maximum effort for 3-5 seconds, and the peak value displayed on the dynamometer is recorded as the result for that trial.
Each leg is tested 2-3 times, with a 60-90 second rest between trials to prevent muscle fatigue from affecting the results.
The average value is recorded as the final outcome.
The unit of measurement is Newtons (N).
|
48 hours after surgery
|
|
Numeric Rating Scale (NRS) Score
Lasso di tempo: 24 and 48 hours after surgery
|
Using a scale from 0 to 10 to indicate pain intensity, where 0 represents no pain and 10 represents the worst possible pain.
|
24 and 48 hours after surgery
|
|
Quadriceps muscle strength grade
Lasso di tempo: 24 and 48 hours after surgery
|
Perform a Manual Muscle Test (MMT).
The patient is placed in the supine position, with a soft pillow under the knee to provide slight flexion, or sits on the edge of the bed with legs hanging naturally.
The examiner stabilizes the patient's thigh with one hand to prevent hip compensation and applies downward resistance with the other hand just above the patient's ankle.
Instruct the patient to forcefully extend the knee against the resistance.
Observe muscle contraction and joint range of motion, and assess according to the 0-5 grade muscle strength scale.
|
24 and 48 hours after surgery
|
|
Knee Joint Range of Motion
Lasso di tempo: 24 and 48 hours after surgery
|
Using a goniometer, accurately measure the patient's knee joint flexion and extension range of motion.
During measurement, the patient is in the supine position.
The axis of the goniometer is aligned with the lateral femoral condyle, the stationary arm is parallel to the long axis of the femur, and the movable arm is parallel to the long axis of the tibia.
Record the angles at full knee extension (0°) and maximum flexion separately.
|
24 and 48 hours after surgery
|
|
Total Opioid Consumption
Lasso di tempo: From the end of the surgery until 72 hours postoperatively
|
Total postoperative consumption of opioids.
|
From the end of the surgery until 72 hours postoperatively
|
|
Postoperative Adverse Reactions
Lasso di tempo: From the end of the surgery until 72 hours postoperatively
|
Including nausea and vomiting, urinary retention, constipation, puncture site ecchymosis and infection, as well as local anesthetic systemic toxicity.
|
From the end of the surgery until 72 hours postoperatively
|
Collaboratori e investigatori
Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.
Investigatori
- Cattedra di studio: Xinli Ni, General Hospital of Ningxia Medical University
Studiare le date dei record
Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.
Studia le date principali
Inizio studio (Stimato)
10 giugno 2026
Completamento primario (Stimato)
30 ottobre 2026
Completamento dello studio (Stimato)
3 novembre 2026
Date di iscrizione allo studio
Primo inviato
27 marzo 2026
Primo inviato che soddisfa i criteri di controllo qualità
26 maggio 2026
Primo Inserito (Effettivo)
29 maggio 2026
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
29 maggio 2026
Ultimo aggiornamento inviato che soddisfa i criteri QC
26 maggio 2026
Ultimo verificato
1 maggio 2026
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Altri numeri di identificazione dello studio
- Qiaojiang Shen-2026-03
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
NO
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
No
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
No
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su a single-injection adductor canal block
-
Ankara Etlik City HospitalIscrizione su invitoArtroplastica totale del ginocchio per gonartrosiTurchia (Türkiye)
-
Glostrup University Hospital, CopenhagenCompletatoLesione del menisco | Dolore (ginocchio) | Artroscopia diagnostica del ginocchio | Piccola chirurgia del ginocchioDanimarca